Kenza Health Hub logoGet Started
1 May 2026Oral drugsSource update: October 2024

Levetiracetam = LEV oral

Levetiracetam guidance for generalized tonic-clonic, focal, and absence seizures, with gradual titration and behavioral monitoring.

Prescription under medical supervision
This guide page is for structured reference only and does not replace a clinician, pharmacist, or emergency review. Dose choice, route choice, interactions, and safety decisions still need professional judgment.

Therapeutic action

Antiseizure (antiepileptic).

Indications

Due to the numerous and potentially severe adverse effects of LEV, patients should be kept under close surveillance.

Epilepsy: generalised tonic-clonic seizures, focal partial seizures, and absence seizures.

Forms and strengths

  • 250 mg, 500 mg, 750 mg, and 1 g tablets.
  • 500 mg/5 ml oral solution, to be administered using a measuring device.

Dose

Start with a low dose then increase gradually based on patient response and tolerance.

  • Child 1 to 5 months: start with 7 mg/kg once daily; increase to 7 mg/kg 2 times daily after 2 weeks, then by increments of 7 mg/kg 2 times daily every 2 weeks if necessary, maximum 21 mg/kg 2 times daily.
  • Child 6 months to 17 years and under 50 kg: start with 10 mg/kg once daily; increase to 10 mg/kg 2 times daily after 2 weeks, then by increments of 10 mg/kg 2 times daily every 2 weeks if necessary, maximum 30 mg/kg 2 times daily.
  • Child 50 kg and over and adult: start with 250 mg 2 times daily; increase to 500 mg 2 times daily after 2 to 4 weeks, then by increments of 500 mg 2 times daily every 2 to 4 weeks if necessary, maximum 1.5 g 2 times daily.

Duration

As long as required. Do not stop treatment abruptly, even if changing to another antiseizure medication.

Contra-indications, adverse effects, precautions

  • Administer with caution to patients with renal impairment by reducing dosage, or with heart disorders.
  • May cause drowsiness, headache, asthenia, dizziness, mood and behavioural disturbances, anxiety, depression, insomnia, haematological disorders, gastrointestinal disturbances, cough, and nasopharyngitis.
  • Rarely, may cause QT prolongation and severe hypersensitivity reactions. In these cases stop treatment. Early symptoms such as fever, rash, mouth ulcers, and bleeding require immediate medical attention.
  • Respiratory depression and coma may occur in overdose.
  • Avoid or monitor the combination with mefloquine, drugs that prolong the QT interval, and sedating medicines including alcohol, benzodiazepines, opioid analgesics, antipsychotics, first-generation antihistamines, antidepressants, and other antiseizure medications.
  • Avoid alcohol during treatment.
  • Pregnancy: use the lowest effective dose and administer folic acid 5 mg daily during the first trimester.
  • Breast-feeding: administer with caution and monitor the child for drowsiness and poor feeding.

Source

MSF Essential drugs practical guidelines (January 2026)

This page reproduces the structured reference information for this batch while leaving out the Storage and Remarks sections.

Rate this guide

Be the first to rate this guide.